This invention relates to 3H-quinazolin-4-one derivatives as defined in the specification and claims, to a process for their preparation, to pharmaceutical compositions comprising them and to their use as selective monoamine oxidase B inhibitors.
本发明涉及规范和声明中定义的3H-
喹唑啉-4-酮衍
生物,它们的制备方法,包含它们的制药组合物以及它们作为选择性单胺氧化酶B
抑制剂的用途。